Informazioni sul prodotto
- 6-(2-Chlorophenyl)-7,10-dihydro-N-(4-methoxyphenyl)-1-methyl-4H-pyrido[4′,3′:4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-9(8H)-carboxamide
- 4H-Pyrido[4′,3′:4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-9(8H)-carboxamide, 6-(2-chlorophenyl)-7,10-dihydro-N-(4-methoxyphenyl)-1-methyl-
- BN 50727
Setipafant is a prodrug that is reconstituted with solvents to form a diluent that can be used in the manufacture of medicines. It is a hydrophobic compound and can be used as a linker for drugs that are insoluble in water. Setipafant has been shown to lower blood pressure by reducing the peripheral vascular resistance and increasing cardiac output. This drug also inhibits nitric oxide release from vascular endothelial cells, which may contribute to its hypotensive effects. The anti-viral activity of setipafant has been demonstrated in vitro against HIV-1, HSV-2, influenza A virus and vesicular stomatitis virus (VSV).
Proprietà chimiche
Richiesta tecnica su: 3D-HFA41835 Setipafant
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
